Vertex / A Cystic Fibrosis Game Changer Continues to Trailblaze
With a total R&D spend of USD 2.66 billion in 2022 and a pipeline that features cutting-edge technologies such as mRNA, cell therapy and gene editing, Vertex Pharmaceuticals is looking…